Key points are not available for this paper at this time.
With 400,000 diagnosed and 180,000 deaths in 2020, renal cell carcinoma (RCC) accounts for 2.4% of all cancer diagnoses worldwide. The highest disease burden developed countries, primarily in Europe and North America. Incidence is projected to increase in the future as more countries shift to Western lifestyles. Risk factors for RCC include fixed factors such as gender, age, and hereditary diseases, as well as intervening factors such as smoking, obesity, hypertension, diabetes, diet and alcohol, and occupational exposure. Intervening factors in primary prevention, understanding of congenital risk factors and the establishment of early diagnostic tools are important for RCC. This review will discuss RCC epidemiology, risk factors, and biomarkers involved in reducing incidence and improving survival.
Building similarity graph...
Analyzing shared references across papers
Loading...
Tomoyuki Makino
Suguru Kadomoto
Kouji Izumi
SHILAP Revista de lepidopterología
Cancers
Kanazawa University
Ishikawa Prefectural Central Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Makino et al. (Mon,) studied this question.
synapsesocial.com/papers/69dcc804a5c75be4cfe54396 — DOI: https://doi.org/10.3390/cancers14164059